| |
| |
|
| Insider
Information: |
Vincent Richard G |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
140,922 |
|
|
Indirect Shares
|
6,360 |
|
|
| Direct
Value |
$48,280 |
|
|
|
Indirect Value
|
$2,179 |
|
|
| Total
Shares |
147,282 |
|
|
| Total
Value |
$50,459 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -15.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sorrento Therapeutics Inc |
SRNE |
|
|
0 |
|
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Chief Financial Officer |
2024-01-03 |
140,922 |
2024-01-03 |
6,360 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2024-01-03 |
4 |
D |
$0.50 |
$4,399 |
D/D |
(8,868) |
140,922 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2023-07-03 |
4 |
D |
$0.36 |
$2,545 |
D/D |
(7,069) |
149,790 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2023-04-13 |
4 |
B |
$0.30 |
$8,961 |
D/D |
30,000 |
156,859 |
2.74 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2023-01-03 |
4 |
D |
$1.02 |
$4,517 |
D/D |
(4,428) |
126,859 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
43,125 |
131,287 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-03-28 |
4 |
B |
$1.40 |
$3,500 |
D/D |
2,500 |
88,162 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-03-25 |
4 |
B |
$1.45 |
$3,706 |
D/D |
2,497 |
85,662 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-03-24 |
4 |
B |
$1.45 |
$4 |
D/D |
3 |
83,165 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-01-28 |
4 |
B |
$1.65 |
$4,125 |
D/D |
2,500 |
83,162 |
2.66 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-01-27 |
4 |
B |
$1.70 |
$17,500 |
D/D |
10,000 |
80,662 |
2.74 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
29,867 |
70,662 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
I/I |
6,360 |
1,834 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Chief Financial Officer |
• – – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
42,628 |
40,794 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
